Chinese 奥乐妥珠单抗 Cited by user 微肿头龙 on 19 Mar 2024 奥乐妥珠单抗(INN:otlertuzumab;开发代号:TRU‐016)是一种靶向CD37 的人源化单克隆抗体,设计用于治疗癌症.
English Otlertuzumab Cited by user Boghog on 15 Jun 2021 Otlertuzumab (TRU‐016) is a humanized monoclonal antibody that targets CD37 designed for the treatment of cancer.